2013 Biotech & Standards Conference Participant: Leonard Freedman

Leonard Freedman
President, Global Biological Standards Institute
Chief Scientific Officer, American Type Culture Collection

Leonard P. Freedman, Ph.D is Chief Scientific Officer, ATCC, and President of the Global Biological Standards Institute (GBSI) in Washington, DC. GBSI is dedicated to advancing life science standards through policy initiatives, thought leadership, and education across the spectrum of biological sciences, including biopharmaceuticals, food and water safety, biodefense and emerging infections, regulatory sciences, and enabling technologies that support these diverse fields. Before joining ATCC and GBSI, Len served as Vice Dean for Research and Professor of Biochemistry and Molecular Biology at Jefferson Medical College, Thomas Jefferson University. Prior to his leadership role at Jefferson, Len was vice president of Discovery for Women’s Health and Musculoskeletal Therapies at Wyeth Research, charged with the discovery of new chemical and bio-therapeutic entities in women’s health and orthopedic disorders. Prior to his role at Wyeth, he was the executive director for the Department of Molecular Endocrinology at Merck Research Labs, as well as adjunct professor of Medicine in the Division of Endocrinology at the University of Pennsylvania.

Dr. Freedman is a recognized leader in the field of nuclear hormone receptors. Early in his career he joined the laboratory of Dr. Keith Yamamoto, one of the world’s leading molecular endocrinologists and focused his research on understanding the molecular mechanisms by which glucocorticoid hormones regulate gene transcription. Len subsequently joined the faculty in Cell Biology & Genetics at Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, where he rose to tenured Full Professor. Len’s lab studied the biological roles of vitamin D3 and retinoid receptors in immune and cancer cells in the context of growth inhibition and differentiation. His lab also defined important new mechanisms by which nuclear receptors mediate transcriptional regulation.

Dr. Freedman has received several research awards, including the Boyer Research Award for Biomedical Research, and was the recipient of numerous grants, including a MERIT award from the NIH. He was also the 2002 recipient of the Ernst Oppenheimer Award from The Endocrine Society.

Len earned a bachelor of arts degree in Biology from Kalamazoo College, and his master of science and Ph.D. in Molecular Genetics from the University of Rochester. He is a member of the American Society for Microbiology, American Society for Biochemistry & Molecular Biology, The Endocrine Society, American Society of Bone and Mineral Research and the New York Academy of Science. He has published extensively and served on numerous scientific review panels. Dr. Freedman has served on the editorial board of Molecular Endocrinology, Endocrinology and Endocrine Reviews, and was an editor of Molecular and Cellular Biology from 2001-2011. Dr. Freedman was a member of the Board of Directors of ATCC and the BioNexus Foundation from 2010-12.